Table 2. WHO diagnosis versus JAK2 V617F... | American Society of Hematology

Table 2.

WHO diagnosis versus JAK2 V617F mutation status and nMEG p-STAT5 staining

WHO diagnosis	JAK2 V617F mutation	nMEG p-STAT5 staining
MDS/MPD-U*	G/T	Positive
MDS/MPD-U	G/T	NA
MDS/MPD-U	G/T	NA
RARS-T†	G/T	Positive
RARS-T	G/T	NA
RARS-T	G/T	NA
RARS-T‡	G/G	Negative
RARS-T	G/T	NA
RARS-T§	G/G	Positive
RARS-T	G/T	NA
RARS-T	G/G	NA
RARS-T∥	T/T	Positive

WHO diagnosis	JAK2 V617F mutation	nMEG p-STAT5 staining
MDS/MPD-U*	G/T	Positive
MDS/MPD-U	G/T	NA
MDS/MPD-U	G/T	NA
RARS-T†	G/T	Positive
RARS-T	G/T	NA
RARS-T	G/T	NA
RARS-T‡	G/G	Negative
RARS-T	G/T	NA
RARS-T§	G/G	Positive
RARS-T	G/T	NA
RARS-T	G/G	NA
RARS-T∥	T/T	Positive

NA indicates not available; nMEG, megakaryocyte nuclear.

Patient 5, Table 2.

Patient 7, Table 3.

Patient 1, Table 3.

Patient 2, Table 3.

Patient 9, Table 3.